148 related articles for article (PubMed ID: 19733036)
1. Efficacy of a new formulation of amphotericin B in murine disseminated infections by Candida glabrata or Candida tropicalis.
Mariné M; Espada R; Torrado J; Pastor FJ; Guarro J
Int J Antimicrob Agents; 2009 Dec; 34(6):566-9. PubMed ID: 19733036
[TBL] [Abstract][Full Text] [Related]
2. The comparative efficacy of cilofungin, fluconazole and amphotericin B in disseminated Candida tropicalis infection in neutropenic mice.
Fong IW; Bannatyne RM; Cheng PC
Clin Invest Med; 1992 Oct; 15(5):434-9. PubMed ID: 1458716
[TBL] [Abstract][Full Text] [Related]
3. Effects of amphotericin B incorporated into liposomes and in lipid suspensions in the treatment of murine candidiasis.
Kretschmar M; Nichterlein T; Hannak D; Hof H
Arzneimittelforschung; 1996 Jul; 46(7):711-5. PubMed ID: 8842344
[TBL] [Abstract][Full Text] [Related]
4. Comparative efficacy and distribution of lipid formulations of amphotericin B in experimental Candida albicans infection of the central nervous system.
Groll AH; Giri N; Petraitis V; Petraitiene R; Candelario M; Bacher JS; Piscitelli SC; Walsh TJ
J Infect Dis; 2000 Jul; 182(1):274-82. PubMed ID: 10882607
[TBL] [Abstract][Full Text] [Related]
5. Efficient treatment of murine systemic infection with Candida albicans using amphotericin B incorporated in nanosize range particles (emulsomes).
Kretschmar M; Amselem S; Zawoznik E; Mosbach K; Dietz A; Hof H; Nichterlein T
Mycoses; 2001; 44(7-8):281-6. PubMed ID: 11714063
[TBL] [Abstract][Full Text] [Related]
6. Amphotericin B lipid complex (ABLC)-associated hypertension: case report and review.
Rowles DM; Fraser SL
Clin Infect Dis; 1999 Dec; 29(6):1564-5. PubMed ID: 10585814
[TBL] [Abstract][Full Text] [Related]
7. In vivo activity of a novel amphotericin B formulation with synthetic cationic bilayer fragments.
Lincopan N; Mamizuka EM; Carmona-Ribeiro AM
J Antimicrob Chemother; 2003 Sep; 52(3):412-8. PubMed ID: 12917237
[TBL] [Abstract][Full Text] [Related]
8. Polymeric carriers for amphotericin B: in vitro activity, toxicity and therapeutic efficacy against systemic candidiasis in neutropenic mice.
Espuelas MS; Legrand P; Campanero MA; Appel M; Chéron M; Gamazo C; Barratt G; Irache JM
J Antimicrob Chemother; 2003 Sep; 52(3):419-27. PubMed ID: 12888593
[TBL] [Abstract][Full Text] [Related]
9. In-vivo therapeutic efficacy in experimental murine mycoses of a new formulation of deoxycholate-amphotericin B obtained by mild heating.
Petit C; Chéron M; Joly V; Rodrigues JM; Bolard J; Gaboriau F
J Antimicrob Chemother; 1998 Dec; 42(6):779-85. PubMed ID: 10052902
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of oral E1210, a new broad-spectrum antifungal with a novel mechanism of action, in murine models of candidiasis, aspergillosis, and fusariosis.
Hata K; Horii T; Miyazaki M; Watanabe NA; Okubo M; Sonoda J; Nakamoto K; Tanaka K; Shirotori S; Murai N; Inoue S; Matsukura M; Abe S; Yoshimatsu K; Asada M
Antimicrob Agents Chemother; 2011 Oct; 55(10):4543-51. PubMed ID: 21788462
[TBL] [Abstract][Full Text] [Related]
11. Neonatal candidosis: clinical picture, management controversies and consensus, and new therapeutic options.
Leibovitz E
J Antimicrob Chemother; 2002 Feb; 49 Suppl 1():69-73. PubMed ID: 11801585
[TBL] [Abstract][Full Text] [Related]
12. Antifungal activity of amphotericin B-lipid admixtures in experimental systemic candidosis in naive mice.
Shadkchan Y; Segal E
J Antimicrob Chemother; 1999 Dec; 44(6):787-90. PubMed ID: 10590279
[TBL] [Abstract][Full Text] [Related]
13. Peritoneal infection with multiple species of Candida: a case report.
Islam S; Zaidi AK; Wilson J
Surg Infect (Larchmt); 2002; 3(1):35-7. PubMed ID: 12593698
[No Abstract] [Full Text] [Related]
14. Antimicrobial activity of AmBisome and non-liposomal amphotericin B following uptake of Candida glabrata by murine epidermal Langerhans cells.
Sperry PJ; Cua DJ; Wetzel SA; Adler-Moore JP
Med Mycol; 1998 Jun; 36(3):135-41. PubMed ID: 9776826
[TBL] [Abstract][Full Text] [Related]
15. Mixed Candida glabrata and Candida albicans disseminated candidiasis in a heroin addict.
Bougnoux ME; Dupont C; Turner L; Rouveix E; Dorra M; Nicolas-Chanoine MH
Eur J Clin Microbiol Infect Dis; 1997 Aug; 16(8):598-600. PubMed ID: 9323473
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of oral cochleate-amphotericin B in a mouse model of systemic candidiasis.
Santangelo R; Paderu P; Delmas G; Chen ZW; Mannino R; Zarif L; Perlin DS
Antimicrob Agents Chemother; 2000 Sep; 44(9):2356-60. PubMed ID: 10952579
[TBL] [Abstract][Full Text] [Related]
17. Successful non-surgical treatment of Candida tropicalis endocarditis with liposomal amphotericin-B (AmBisome).
Melamed R; Leibovitz E; Abramson O; Levitas A; Zucker N; Gorodisher R
Scand J Infect Dis; 2000; 32(1):86-9. PubMed ID: 10716084
[TBL] [Abstract][Full Text] [Related]
18. Mild heating of amphotericin B-desoxycholate: effects on ultrastructure, in vitro activity and toxicity, and therapeutic efficacy in severe candidiasis in leukopenic mice.
van Etten EW; van Vianen W; Roovers P; Frederik P
Antimicrob Agents Chemother; 2000 Jun; 44(6):1598-603. PubMed ID: 10817715
[TBL] [Abstract][Full Text] [Related]
19. Fatal outcome of disseminated candidosis after allogeneic bone marrow transplantation under treatment with liposomal and conventional amphotericin-B. A report of 4 cases with determination of the Mic values.
Krüger W; Sobottka I; Stockschläder M; Mross K; Hoffknecht M; Rüssmann B; Horstmann M; Betker R; Zander A
Scand J Infect Dis; 1996; 28(3):313-6. PubMed ID: 8863370
[TBL] [Abstract][Full Text] [Related]
20. Comparative effects of cilofungin and amphotericin B on experimental murine candidiasis.
Morrison CJ; Stevens DA
Antimicrob Agents Chemother; 1990 May; 34(5):746-50. PubMed ID: 2193617
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
